Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined

Head and neck cancers account for more than 550,000 cases and 380,000 deaths annually worldwide and are the 6^th most common cancer type (1). Head and neck cancers can arise in the oral cavity, pharynx, larynx, nasal cavity, paranasal sinuses, thyroid, and salivary glands and include a variety of histopathologic tumors. Squamous cell cancer (SCC) is the most common pathological type of head and neck cancer (2).